baber/WOPTO huggingface dataset:
Patent JP-3929482-B2 (JP)
IPC: C09K23/52
Filed: 1994-07-25
Granted: 2007-06-13
Abstract: PCT No. PCT/EP94/02450 Sec. 371 Date Feb. 1, 1996 Sec. 102(e) Date Feb. 1, 1996 PCT Filed Jul. 25, 1994 PCT Pub. No. WO95/04035 PCT Pub. Date Feb. 9, 1995A liquid composition comprising A) at least one sulosuccinic acid diester of the formula:  in which M is an inorganic or organic cation, R and R' independently of one another represent aliphatic or cycloaliphatic C3-22 alkyl, C2-22 alkenyl or optionally C1-8 alkyl-substituted C6-22 aryl; B) water as a solvent; and C) a cosolvent consisting essentially of at least one polymer containing alkylene oxide units which is liquid at 10 DEG  C.
Patent JP-2573791-B2 (JP)
IPC: H02N2/00
Filed: 1992-10-16
Granted: 1997-01-22
Abstract: An actuator for tilting the plane of an object is constructed from a stack of piezoelectric or electrostrictive members. First alternate interstices between the members are filled with a first conductive material, except that a first gap remains between the material and one side of the stack. Similarly, second alternate interstices between the members are filled with a second conductive material, except that a second gap remains between the material and an opposite side of the stack. The first gap and the second gap have unequal depth into the stack. The first material in the first interstices is coupled in common and the second material in the second interstices is coupled in common. A voltage applied between the first material and the second material will thereby cause the stack to bend, thereby tilting the plane of the op of the stack.
Patent JP-3977434-B2 (JP)
IPC: C12N5/02
Filed: 1997-08-01
Granted: 2007-09-19
Abstract: The present invention provides for a modified TIE-2 ligand 2 which has been altered by addition, deletion or substitution of one or more amino acids, or by way of tagging, with for example, the Fc portion of human IgG-1, but which retains its ability to bind the TIE-2 receptor.
Patent JP-2761545-B2 (JP)
IPC: B42F5/02
Filed: 1989-08-30
Granted: 1998-06-04
Abstract: Framing apparatus for framing snap shots and the like, including a flexible rectangular-shaped transparent sheet having an opaque frame printed about its perimeter. A pressure sensitive adhesive coating is coextensive with the aforementioned opaque frame. A transparent sheet of much thinner gauge than the first-mentioned sheet is releasably secured to the pressure sensitive adhesive coating. The unassembled frame is moved about the snap shot or picture to be framed. The transparent nature of the assembly facilitates viewing of the picture therebeneath, enabling the user to select any portion of the picture. A writing instrument may be employed to form an outline of the frame on the picture, or the thin gauge cover sheet may be removed and the photograph pressed against the heavy plastic sheet. The portion of the picture extending beyond the frame is cut away from the part of the picture being framed. The heavy gauge flexible sheet serves as an excellent guide for cutting the photograph about the frame without any danger of damaging the frame. When the picture is cut out before mounting, the thin gauge cover sheet is then removed and the photograph pressed against the heavy gauge plastic sheet. The opaque frame conceals the possible rough edged perimeter of the photograph providing a nicely finished laminated photograph and frame assembly. An alternative embodiment provides a foldable flexible transparent sheet for mounting and framing plural graphic material in a back-to-back fashion.
Patent JP-3213314-B2 (JP)
IPC: A61K35/14
Filed: 1992-04-03
Granted: 2001-10-02
Abstract: The present invention relates to monoclonal antibodies specific for a cell receptor specific for human stem cell factor (hSCF) as well as pharmaceutical compositions containing such monoclonal antibodies and uses of such monoclonal antibodies.
Patent JP-3859705-B2 (JP)
IPC: C01B33/14
Filed: 1995-10-10
Granted: 2006-12-20
Abstract: PCT No. PCT/EP95/03989 Sec. 371 Date Apr. 17, 1997 Sec. 102(e) Date Apr. 17, 1997 PCT Filed Oct. 10, 1995 PCT Pub. No. WO96/12683 PCT Pub. Date May 2, 1996The invention relates to a composition comprising between 30 and 95% by volume of aerogel particles and at least one aqueous binder, where the particle diameter of the aerogel particles is less than 0.5 mm and the aerogel particles preferably have hydrophobic surface groups, a process for the preparation thereof, and the use thereof.
Patent JP-3587852-B2 (JP)
IPC: F21V8/00
Filed: 1994-10-18
Granted: 2004-11-10
Abstract: An improved backlight assembly comprising an array of apertures in close proximity to a light source, an array of tapered optical elements that have a light input surface area smaller than the light output surface area. Light rays pass through the apertures and are directed to the optical elements which transmit the light rays via internal reflection to provide a partially collimated light source. The light rays then pass through an array of microlenses that transmit the light rays via refraction and provide a substantially more collimated light source for the display elements of a display. The backlight assembly is advantageously used as a backlighting means for electro-optical displays, especially those designed for military and avionics applications.
Patent JP-2823692-B2 (JP)
IPC: A61F2/16
Filed: 1993-02-25
Granted: 1998-11-11
Abstract: An intraocular lens for implantation in an eye comprising a deformable silicone optic configured so that the optic can be deformed to permit the intraocular lens to be passed through a scleral tunnel incision no longer than about 3.2 mm into the eye. The intraocular lens can be provided in a range of diopter powers. When the intraocular lens is implanted in the eye, the optic has sufficient rigidity to be substantially free of optical distortion resulting from force from the eye acting on the intraocular lens and the optic is of sufficient size to substantially prevent glare resulting from interaction of light and the periphery of the optic.
Patent JP-3220149-B2 (JP)
IPC: H04M1/72511
Filed: 1993-03-18
Granted: 2001-10-22
Abstract: A communications system has first and second communications units (e.g. a base station and a handset of a CT2 or DECT telepoint system) with means for communicating over a base set of communications channels, means for selecting one of said base set for establishing communication and means in said first unit for communicating to said second unit information as to extended channel capabilities, in addition to the base set of said first unit when communication has been established. The first unit can also communicate the spectral location of the extended channels to the second unit. Where possible channel outside the base set is selected for further communication between the units to keep the base set free for use by units not having extended channel capability. Upper and lower limits of a receiver filter can be set to match the channels selected. <IMAGE>
Patent JP-2818298-B2 (JP)
IPC: A61K38/00
Filed: 1993-04-20
Granted: 1998-10-30
Abstract: A pharmaceutical composition containing ([3'-desoxy-3'-oxo-MeBmt]<1>-[Val]<2>-Ciclosporin) as an active ingredient. The composition is formulated as a microemulsion or microemulstion preconcentrate using a carrier medium comprising a hydrophilic phase; a transesterified ethoxylated vegetable oil; and a surfactant. The composition has good stability and biopharmaceutical properties and is useful in the treatment of multiple drug resistance syndrome in humans.
Patent JP-3739793-B2 (JP)
IPC: B67D3/02
Filed: 1996-01-09
Granted: 2006-01-25
Abstract: A dispenser comprises a collapsible bottle and a valve assembly for placement in the throat of the bottle which includes a first hollow valve member sealed in the throat of the bottle and a hollow second valve member having apertures in the side wall. The second valve member telescopes in the first valve member between a closed position in which the apertures are located within the channel of the first valve member to close the bottle and an open position in which the apertures are in flow communication with the interior of the bottle. The first and second valve members are dimensioned to receive a probe forming part of a dispenser pump mechanism. The bottle is provided with crease lines located on the front, back and sides so that the bottle collapses as liquid is pumped out of the bottle to prevent exposure of the liquid contents to air.
Patent JP-4191242-B2 (JP)
IPC: A61F13/62
Filed: 1995-04-11
Granted: 2008-12-03
Abstract: PCT No. PCT/SE95/00389 Sec. 371 Date Sep. 30, 1996 Sec. 102(e) Date Sep. 30, 1996 PCT Filed Apr. 11, 1995 PCT Pub. No. WO95/27460 PCT Pub. Date Oct. 19, 1995A pant diaper or a sanitary panty which includes a front part, a rear part, and an intermediate crotch part, which includes an absorbent body enclosed between an inner and an outer casing sheet. The front part is detachably joined to the rear part by means of a first fastening. A piece of flexible material extends over the front part and is joined thereto over a larger part of its surface by means of a first releasable fastening, which extends on both sides of a centrally located region of the piece of material, from the edges of the central region to the respective side edges of the front part. The piece of material is also joined to the rear part.
Patent JP-4166835-B2 (JP)
IPC: A61B17/122
Filed: 1997-12-19
Granted: 2008-10-15
Abstract: The present invention relates to a self-expanding device for sealing a defect in a wall, such as a septal defect. The device of the present invention has a fluoropolymer membrane that is supported by an embedded wire structure having elastic properties which is capable of being compressed and inserted in the defect by a catheter and thereafter returning to its memory induced configuration. The device of the present invention can be employed in a variety of applications where a small hole needs to be sealed. <IMAGE>
Patent JP-3606581-B2 (JP)
IPC: A61M13/00
Filed: 1995-05-26
Granted: 2005-01-05
Abstract: PCT No. PCT/FI95/00291 Sec. 371 Date Nov. 25, 1997 Sec. 102(e) Date Nov. 25, 1997 PCT Filed May 26, 1995 PCT Pub. No. WO95/32752 PCT Pub. Date Dec. 7, 1995The invention relates to a medicament chamber (6) included in an inhalation apparatus and provided with a container (2) containing a desiccant. The chamber (6) is tightly sealed and has a moisture permeability as poor as possible, and the container (2) is permeable to moisture.
Patent JP-4036472-B2 (JP)
IPC: A61K47/48
Filed: 1996-04-12
Granted: 2008-01-23
Abstract: This invention provides a heterotelechelic oligomer or polymer which is represented by the following formula: <CHEM> wherein A denotes a sugar residue, L denotes a linkage group represented by the following formula <CHEM>  or  &lparstr& CH2 &rparstr& 4   wherein R<1> and R<2> independently denote lower alkyl, aralkyl or aryl, X denotes a single bond or -CH2CH2-, Z denotes a group forming an unsaturated ester or ether, or a functional group such as halogen which binds to -CH2CH2-, n denotes an integer of 5 - 10,000, and m denotes an integer of 0 or 2 - 10,000.   This invention also provides a process to produce the above oligomer or polymer, and further a high molecular-micelle with use of a polyethylene oxide-polyester block polymer which has a sugar residue at its terminal. Said oligomer or polymer is expected to exhibit excellent bioavailability, and is also expected to be utilized in the field such as carriers for drug delivery or diagnostic reagents.
Patent JP-4001927-B2 (JP)
IPC: A61K9/70
Filed: 1998-02-09
Granted: 2007-10-31
Abstract: A transdermal or topical plaster system with a backing layer, with an active ingredient-containing and self-adhesive matrix based on crosslinkable polyacrylate as base polymer and with a removable protecting film is characterized by an at least two-layer matrix with a degree of crosslinking of the layer facing the skin which is appropriate for adequate adhesion to the skin thereof and is lower than the degree of crosslinking of the layer or layers on top thereof.
Patent MD-3958-B2 (MD)
Inventor: SCHILIOV VLADIMIR
IPC: B41M5/00
Filed: 2007-01-22
Abstract: Inventia se refera la domeniul identificarii resurselor materiale si poate fi utilizata pentru marcarea pieselor electroconductoare, de exemplu, a produselor laminate, pieselor mijloacelor de transport, produselor industriei constructiilor de masini, de avioane, etc. Procedeul consta in aceea ca suprafata marcajului de identificare se divizeaza in doua parti: neschimbatoare si schimbatoare. Pe partea neschimbatoare a marcajului, care contine un numar de identificare, se aplica o imagine nereproductibila. Partea schimbatoare a marcajului se divizeaza in cateva sectoare, in conformitate cu numarul de etape ale procesului tehnologic, pe care trebuie sa le parcurga piesa de identificat. Fiecare sector al partii schimbatoare se completeaza cu informatie de identificare imediat dupa trecerea piesei de identificat a etapei ordinare a procesului tehnologic. La efectuarea fiecarei etape a procesului tehnologic suprafetele schimbatoare si neschimbatoare ale marcajului de identificare, cu exceptia sectorului partii schimbatoare corespunzator etapei ordinare a procesului tehnologic, se acopera cu un sablon dielectric adeziv de folosinta multipla.
Patent ES-2238009-B2 (ES)
Title: Eje intermedio de baja carga de deslizamiento de la columna de direccion de vehiculos automoviles.
Inventor: DAUMAL CASTELLON MELCHOR
IPC: F16C3/03
Filed: 2004-01-28
Granted: 2007-07-16
Abstract: Eje intermedio de baja carga de deslizamiento de la columna de dirección de vehículos automóviles. Comprende un elemento hembra que aloja por deslizamiento un elemento macho y una serie de flejes metálicos, por ejemplo tres, montados entre los mismos. Los flejes quedan retenidos en posición al encontrarse alojados en las cavidades de una jaula de sujeción inmovilizada en la superficie exterior del elemento macho. Permiten garantizar la fricción por desplazamiento longitudinal de ambos elementos eliminando holguras y juegos radiales con una total eficacia en la transmisión de par en cualquier momento.
Patent ES-2369297-B2 (ES)
Title: Balanza para túnel aerodin�?mico.
Inventor: GONZALEZ HERNANDEZ MIGUEL A
IPC: G01L5/16
Filed: 2011-05-24
Granted: 2012-03-12
Abstract: Balanza para túnel aerodinámico, que comprende:#- una estructura fija (1),#- una estructura flotante (2),#- al menos seis barras (3, 3, 3, 4, 4, 5) de medición de fijación isostática de la estructura fija (1) a la estructura flotante (2), mecánicamente desacopladas, y unidas por uno de sus extremos a la pieza flotante (2) y por el otro a la estructura fija (1), que comprenden, cada una, medios de medición de cargas de tracción-compresión,#dispuestas las barras de tal manera que durante la ejecución del ensayo en el túnel aerodinámico, cada barra mida una componente de la fuerza del modelo a ensayar, dispuesto sobre la estructura flotante (2), independientemente de la que miden las demás.
Patent ES-2628277-B2 (ES)
Title: Planta de generación de hidrógeno para instalación a bordo de buques GNL
Inventor: ARIAS FERNANDEZ IGNACIO
IPC: C01B3/34
Filed: 2016-02-02
Granted: 2017-12-29
Abstract: Planta de generación de hidrógeno para instalación a bordo de buques GNL, que permite la obtención de hidrógeno a partir del exceso de BOG generado a bordo mediante un proceso de reformado, aumentando el rendimiento global de la instalación. Para aumentar la eficiencia del módulo de obtención de hidrógeno también se realiza el aprovechamiento del calor residual generado en el buque.#El hidrógeno se puede almacenar bajo presión en tanques independientes en el interior de los propios tanques de carga del buque a temperatura criogénica. El hidrógeno se puede utilizar como combustible en el sistema de generación eléctrica o propulsión con la única emisión de vapor de agua por los escapes, pudiendo navegar por zonas ECA o con limitaciones de emisiones sin ningún problema.
Patent IE-S86306-B2 (IE)
Title: Antisense oligonucleotides or oligonucleotide analogues
Inventor: LESTER DOUGLAS
IPC: A61K31/00
Filed: 2013-03-26
Abstract: The present invention relates to antisense oligonucleotides or oligonucleotide analogues adapted to target pre-mRNA which encodes GNB3s and prevent aberrant splicing events. In particular the invention relates to non-natural oligonucleotides, especially morpholino oligonucleotides. Such oligonucleotides have the potential to treat various medical conditions. The invention also provides, pharmaceutical compositions, methods of using the oligonucleotides, for example in medical treatments.
Patent AU-2001269328-B2 (AU)
Title: Supported polymerisation catalysts
Inventor: MEALARES CHRISTEL MARIE-CLAUDE
IPC: C07F7/28
Filed: 2001-07-11
Granted: 2005-01-20
Abstract: Supported ionic metallocene catalyst systems may be prepared by a method comprising the following steps: i) mixing together in a suitable solvent: a) an organometallic compound, and b) an ionic activator comprising a cation and an anion; ii) addition of the mixture from step (i) to a support material; iii) addition of a metallocene complex in a suitable solvent; iv) further addition of an organometallic compound in a suitable solvent; and v) removal of the solvent. The preferred supported catalysts comprise a constrained geometry metallocene complex for example (t-butylamido)(tetramethyl--><5>-cyclopentadienyl) dimethyl silanetitanium--><4>-1,3-pentadiene and are particularly suitable for the polymerisation of ethylene or the copolymerisation of ethylene and alpha-olefins having from 3 to 10 carbons in the gas phase. The supported metallocene catalysts of the present invention show improved productivity compared to supported ionic metallocene catalyst systems of the prior art particularly when used in the gas phase.
Patent AU-2002210536-B2 (AU)
Title: Detection of pathogenic bacteria
Inventor: BERGHOF KORNELIA
IPC: C12Q1/689
Filed: 2001-10-15
Granted: 2006-07-13
Abstract: The object of the invention are oligonucleotides which can be used for the detection of pathogenic bacteria. With the aid of these oligonucleotides a method can be applied which enables the selection of pathogenic bacteria from non-pathogenic bacteria. Preferably the detection of the bacteria includes a PCR. Oligonucleotides are also provided which can be used as a positive control for the PCR.
Patent AU-2002223449-B2 (AU)
Title: Method for isolating pharmaceutically exploitable etidronate disodium
Inventor: GRAWE DETLEF
IPC: C07F9/38
Filed: 2001-09-28
Granted: 2007-03-22
Abstract: The method of isolating an anhydrous etidronate disodium particulate includes preparing a liquid-liquid dispersion consisting of an aqueous-organic phase and an etidronate-disodium-salt-containing aqueous phase; adjusting a temperature of the liquid-liquid dispersion to between 0 and 30° C. and intensely agitating so that a coarse-particle fraction precipitates from the liquid-liquid dispersion, then drawing off a fine-particle suspension and allowing a fine-particle fraction to precipitate from it and filtering and drying the coarse particle fraction. In a preferred embodiment the fine-particle fraction is separated from the fine-particle suspension for recycling The resulting anhydrous etidronate disodium particulate has a grain size of from about 0.1 to 1 mm and a bulk density of 0.4 to 0.6 g/cm<SUP>2 </SUP>with good properties for pharmaceutical applications.
Patent AU-2002231823-B2 (AU)
Title: Dental and medical polymer composites and compositions
Inventor: VALLITTU PEKKA
IPC: A61K6/884
Filed: 2002-02-06
Granted: 2006-02-23
Abstract: The invention relates to polymerisable multifunctional polymer composites and compositions, which are suitable for dental and medical applications, such as dental prostheses, filling materials, implants and the like. It also relates to a method for the manufacture of such polymerisable multifunctional polymer composites and compositions, and to the use of said multifunctional polymer composites and compositions in dental and medical applications. A multifunctional polymer composite or composition is manufactured from 30-99 wt% of a monomer mixture containing 30-99 wt% of a dendrimer or a combination of dendrimers and 1-70 wt% of a reactive solvent or a combination of reactive solvents, and 0.1-70 wt% of a nanofiller or a combination of nanofillers.
Patent AU-2002237341-B2 (AU)
Title: A method for the removal of calcium from a zinc process sulfate solution
Inventor: TALONEN PANU
IPC: C25C1/16
Filed: 2002-03-08
Granted: 2007-01-25
Abstract: The invention relates to a method for removing calcium from a sulfate solution in the zinc production process. Calcium is removed as an anhydrate from the raw solution coming from concentrate or ore leaching before the solution purification stages.
Patent AU-2002250853-B2 (AU)
Title: Steel and method for producing an intermediate product
Inventor: ERNST CLAUDIA
IPC: C21D7/13
Filed: 2002-01-25
Granted: 2006-08-03
Abstract: The present invention relates to a steel, in particular for tools exposed to corrosion, of the following composition (in mass-%): C: min. 0.02 and max. 0.12%; Si: max. 1.5%; Mn: more than 1.0-2.50%; P: max. 0.035%; S: min. 0.04% and less than 0.15%; Cr: more than 8.0% and less than 12%; Mo: more than 0.0% and max. 0.20%; V: more than 0.0% and max. 0.25%; Nb: more than 0.1% and max. 0.5%; N: at least 0.02% and max. 0.12%; Ni: max. 0.5%; B: max. 0.005%; Cu: max. 0.3%; Al: max. 0.035%; Sn: max. 0.035%; As: max. 0.02%; at least one of the elements Ca, Mg or Ce, wherein the sum of the contents of these elements is at least 0.0002% and max. 0.015%; with the remainder being iron and unavoidable impurities.
Patent AU-2003201309-B2 (AU)
Title: Swab Testing Device and Method
Inventor: SUGIYAMA NOBUYUKI
IPC: G01N33/48
Filed: 2003-03-17
Granted: 2007-05-24
Abstract: A swab testing device comprises a container (1) containing a diluent (7), a cap (10, 20) detachably mounted on an opening of the container, an elongating stick (4) secured to or integral with the cap, and a cotton swab (5) connected to a leading end of the stick and immersed in the diluent when the container opening is closed with the cap. The cap provides a communicating channel (12, 14, 27, 31) communicatable with the interior (6) of the container and also communicatable with the atmosphere by an aperture (23a) formed on the cap. The cap also includes a lid (15, 25) by which the aperture may be opened and closed. Any liquid in the container may be discharged through the communicating channel and the aperture, when the lid is opened to communicate the channel with the atmosphere through the aperture, even when the container opening remains closed with the cap. <IMAGE> <IMAGE>
Patent AU-2003229552-B2 (AU)
Title: Coupling low-molecular substances to hydroxyalkyl starch
Inventor: EICHNER WOLFRAM
IPC: A61K47/36
Filed: 2003-02-28
Granted: 2009-06-11
Abstract: New conjugates of hydroxyalkyl starch (HAS) and small molecules comprise a covalent linkage between terminal aldehyde groups of the HAS, or functional groups formed by chemical conversion of the terminal aldehyde groups, and functional groups of the small molecule that are reactive with the aldehyde groups or derived functional groups. New conjugates of hydroxyalkyl starch (HAS) and small molecules comprise a covalent linkage between terminal aldehyde groups of the HAS, or functional groups formed by chemical conversion of the terminal aldehyde groups, and functional groups of the small molecule that are reactive with the aldehyde groups or derived functional groups. The bond formed as a direct result of the coupling reaction can be modified by a further reaction to produce the covalent linkage. Independent claims are also included for: (1) production of the conjugates by performing the coupling reaction in an aqueous medium and optionally modifying the resulting bond, and (2) selective oxidation of terminal aldehyde groups by reacting hydroxyalkyl starch with 2-20 molar equivalents of iodine in an aqueous basic medium or with a molar excess of stabilized copper (Cu 2+>) or silver (Ag +>) ions in an aqueous alkaline medium.